Kosei Hasegawa

38PUBLICATIONS
200CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical ethics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Sep 17, 2026
Survey on the current status of novel cancer drug therapies for gynecological cancers in Japan: a nationwide survey by the Japan Society of Obstetrics and Gynecology (JSOG).

|Aug 07, 2026
cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer.

|Mar 21, 2026
Direct comparison of 5-aminolevulinic acid photodynamic diagnosis and white light inspection for detecting peritoneal dissemination in advanced ovarian cancer: a pilot study.

Akira Yabuno, Daisuke Shintani, Masakazu Sato

|Jul 01, 2025
Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis.

Yong-Man Kim, Shin Nishio, Se Ik Kim

|Jun 23, 2025
Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models.

Shigehiro Yagishita, Sho Sato, Daisuke Shintani

|Apr 09, 2025
BRCA1 Promoter Methylation in Ovarian Cancer: Clinical Relevance and a Novel Diagnostic Approach Using Fragment Analysis.

Saki Tsuchimochi, Yoko Yamamoto, Ayumi Taguchi

Pageof 7

Frequent Collaborators

10 joint publications

Kazuhiro Takehara

8 joint publications

Daisuke Shintani

7 joint publications

Kan Yonemori

6 joint publications

Daisuke Aoki